ACORN BIOVENTURES
Our invest in and partner with private and small capitalization biotech, specialty pharma and medical device companies.
ACORN BIOVENTURES
Social Links:
Founded:
2017-01-01
Status:
Active
Contact:
212 299-4770
Technology used in webpage:
U.S. Server Location
Similar Organizations
Cherrystone Angel Group
Providence based angel group interested in biopharma, medical device and tech startups in New England.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Rittenhouse Ventures
Rittenhouse Ventures provides capital & growth strategies with advanced software solutions for healthcare, financial and business services..
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-04-09 | Acrivon Therapeutics | Acorn Bioventures investment in Post-IPO Equity - Acrivon Therapeutics | 130 M USD |
| 2024-04-05 | Protara Therapeutics | Acorn Bioventures investment in Post-IPO Equity - Protara Therapeutics | 45 M USD |
| 2024-04-03 | Neurosterix | Acorn Bioventures investment in Series A - Neurosterix | 63 M USD |
| 2024-03-25 | Q32 Bio | Acorn Bioventures investment in Post-IPO Equity - Q32 Bio | 42 M USD |
| 2024-03-13 | Cybin | Acorn Bioventures investment in Post-IPO Equity - Cybin | 150 M USD |
| 2023-12-12 | Bicara Therapeutics | Acorn Bioventures investment in Series C - Bicara Therapeutics | 165 M USD |
| 2023-10-30 | VYNE Therapeutics | Acorn Bioventures investment in Post-IPO Equity - VYNE Therapeutics | 88 M USD |
| 2023-08-02 | CG Oncology | Acorn Bioventures investment in Series F - CG Oncology | 105 M USD |
| 2023-05-23 | OnKure Therapeutics | Acorn Bioventures investment in Series C - OnKure Therapeutics | 54 M USD |
| 2023-03-06 | Bicara Therapeutics | Acorn Bioventures investment in Series B - Bicara Therapeutics | 108 M USD |
More informations about "Acorn Bioventures"
Acorn Bioventures
Acorn Bioventures invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. Our investment flexibility allows us to …See details»
Acorn Bioventures - Crunchbase Company Profile
Acorn Bioventures is a private and small capitalization biotech, specialty pharma and medical device companies.See details»
Acorn Bioventures - Financial Details - Crunchbase
Acorn Bioventures is a private and small capitalization biotech, specialty pharma and medical device companies.See details»
Acorn Bioventures - Investor Profile and Portfolio - Tracxn
Jul 29, 2025 Explore Acorn Bioventures' in-depth investor profile, including top investments, portfolio trends, leadership team, co-investors, and news updates.See details»
Acorn Bioventures investment portfolio | PitchBook
General Information Company Description Founded in 2017, Acorn Bioventures is a venture capital investment firm based in New York, New York. The firm seeks to invest in companies operating in the biotechnology, pharmaceutical, medical …See details»
Acorn Bioventures Investor Information - Funding, Portfolio …
Acorn Bioventures provides financial support to early-stage health-related businesses, particularly in biotechnology and health technology. They invest between $500k and $10M to assist in product …See details»
Acorn Bioventures - LinkedIn
Acorn Bioventures | 372 followers on LinkedIn. Investing in private and small capitalization biotech, specialty pharma and medical device companies. | We invest in and partner with private and ...See details»
ACORN BIOVENTURES, L.P. Top 13F Holdings - WhaleWisdom.com
Detailed Profile of ACORN BIOVENTURES, L.P. portfolio of holdings. SEC Filings include 13F quarterly reports, 13D/G events and more.See details»
Acorn Bioventures Company Profile | Management and Employees List
Find contact information for Acorn Bioventures. Learn about their Investment Banking, Finance market share, competitors, and Acorn Bioventures's email format.See details»
Acorn Bioenergy
Acorn Bioenergy is a developer of anaerobic digestion sites expected to become the leading biomethane and green CO2 producer nationwide.See details»
Acorn Bioventures - Venture Capital Firm | Signal - NFX
Acorn Bioventures invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. Our investment flexibility allows us to …See details»
Acorn Bioventures, L.p. Portfolio Holdings - Fintel
Acorn Bioventures, L.p. Portfolio Holdings13D/G Filings This is a list of 13D and 13G filings made in the last year (if any). Click the link icon to see the full transaction history. Green rows indicate new …See details»
Acorn Bioventures - Private Equity International
Acorn Bioventures News, insights, analysis and data Acorn Bioventures overview Founded in 2017, Acorn Bioventures is a New York-based investment firm that focuses on biotech-related Sectors …See details»
Acorn Bioventures - News & Analysis - Crunchbase
Jun 24, 2025 Acorn Bioventures is a private and small capitalization biotech, specialty pharma and medical device companies.See details»
Acorn Bioventures Management Team | Org Chart - RocketReach
Acorn Bioventures employs 4 employees. The Acorn Bioventures management team includes Anders Hove (Partner and Founder), Max Lewin (Vice President), and Isaac Manke (Partner).See details»
Acorn 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Acorn. Use the PitchBook Platform to explore the full profile.See details»
Sec Form 13G Filing - ACORN BIOVENTURES, L.P. @ BioAtla, Inc.
ACORN BIOVENTURES, L.P. Signature: Anders Hove Name/Title: Manager Date: 05/20/2025 ACORN BIOVENTURES 2, L.P. Signature: Anders Hove Name/Title: Manager Date: 05/20/2025 …See details»
ACORN BIOVENTURES, L.P. Schedule 13G Filing Concerning CADL on …
Jun 25, 2025 ACORN BIOVENTURES, L.P. Schedule 13G Filing Concerning CADL on 2025-06-25See details»
Acorn Bioventures - Investor in New York, New York - Ask For Funding
Acorn Bioventures invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. Our investment flexibility allows us to …See details»
Acorn BioVentures 2 LP | AUM 13F
Public filings of Acorn BioVentures 2 LP raised by Acorn Capital Advisors LLC. Direct links to the EDGAR source material.See details»